new york reuters us stocks finished little changed wednesday nasdaq first session five investors grappled evolving situation ukraine shrugged concern weakness chinas economy
eu agreed framework first sanctions russia since cold war stronger response ukraine crisis many expected mark solidarity washington effort make moscow pay seizing crimea
london copper prices proxy economic health due metals broad industrial use hit lowest since july 2010 concerns credit problems china later rebounded copper fallen 77 percent four sessions spot gold hit sixmonth high safehaven appeal
situation ukraine slowing china going matter havent mattered yet commodity prices falling tied demand said kim forrest senior equity research analyst fort pitt capital group pittsburgh
however money sidelines investors worried missing another leg fiveyear us equity bull market keeping indexes near recent highs
people think missed market going last year said theres retail money flowing system supporting stocks
dow jones industrial average dji fell 1117 points 007 percent 1634008 sp 500 spx gained 057 points 003 percent 18682 nasdaq composite ixic added 16144 points 037 percent 4323332
geopolitical developments moved forefront week lack major corporate results marketmoving economic data sp 500 rose 30 percent last year recent decline hit record high last friday
weve climbed far continue climb definitely going seesaw move said rick meckler president libertyview capital management jersey city new jersey
herbalife hlfn fell 74 percent 6057 company said us federal trade commission opened inquiry operations shares briefly fell much 16 percent
shares fannie mae freddie mac fell sharply day leaders senate banking committee announced agreement legislation wind governmentowned mortgage financiers fannie lost 122 percent 354 freddie fell 168 percent 336
epl oil gas inc jumped 288 percent 3750 company agreed acquired larger rival energy xxi ltd 23 billion including debt energy xxi shares lost 78 percent 2154
express inc dropped 12 percent 1605 apparel retailer reported fourthquarter earnings forecast profit current quarter fell far short analyst expectations
oxigene inc surged 773 percent 429 company said experimental drug zybrestat combined roches rogvx cancer drug avastin significantly slowed progression recurrent ovarian cancer better avastin alone midstage clinical trial
geron corp plunged 616 percent 169 company said us food drug administration ordered halt trials cancer drug concerns potential liver damage
64 billion shares traded us exchanges according latest available data bats global markets 69 billion daily average far month
advancers outnumbered decliners 7 5 nyse nasdaq 9 issues rose every 7 fell
